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Abstract:  Microorganisms are ubiquitous in all habitats and are recognized by their 
metabolic versatility and ability to produce many bioactive compounds, including toxins. 
Some of the most common toxins present in water are produced by several cyanobacterial 
species. As a result, their blooms create major threats to animal and human health, tourism, 
recreation and aquaculture. Quite a few cyanobacterial toxins have been described, 
including hepatotoxins, neurotoxins, cytotoxins and dermatotoxins. These toxins are 
secondary metabolites, presenting a vast diversity of structures and variants. Most of 
cyanobacterial secondary metabolites are peptides or have peptidic substructures and are 
assumed to be synthesized by non-ribosomal peptide synthesis (NRPS), involving peptide 
synthetases, or NRPS/PKS, involving peptide synthetases and polyketide synthases hybrid 
pathways. Besides cyanobacteria, other bacteria associated with aquatic environments are 
recognized as significant toxin producers, representing important issues in food safety, 
public health, and human and animal well being. Vibrio species are one of the most 
representative groups of aquatic toxin producers, commonly associated with seafood-born 
infections. Some enterotoxins and hemolysins have been identified as fundamental for 
V. cholerae and V. vulnificus pathogenesis, but there is evidence for the existence of other 
potential toxins. Campylobacter spp. and Escherichia coli are also water contaminants and 
are able to produce important toxins after infecting their hosts. Other bacteria 
associated  with aquatic environments are emerging as toxin producers, namely 
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Legionella pneumophila and Aeromonas hydrophila, described as responsible for the 
synthesis of several exotoxins, enterotoxins and cytotoxins. Furthermore, several 
Clostridium species can produce potent neurotoxins. Although not considered aquatic 
microorganisms, they are ubiquitous in the environment and can easily contaminate 
drinking and irrigation water. Clostridium members are also spore-forming bacteria and 
can persist in hostile environmental conditions for long periods of time, contributing to 
their hazard grade. Similarly, Pseudomonas species are widespread in the environment. 
Since P. aeruginosa is an emergent opportunistic pathogen, its toxins may represent new 
hazards for humans and animals. This review presents an overview of the diversity of 
toxins produced by prokaryotic microorganisms associated with aquatic habitats and their 
impact on environment, life and health of humans and other animals. Moreover, important 
issues like the availability of these toxins in the environment, contamination sources and 
pathways, genes involved in their biosynthesis and molecular mechanisms of some 
representative toxins are also discussed. 
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1. Introduction 
Toxins are any poisonous substance produced by a living organism that is capable of causing 
disease or death in other organisms. In several cases, the same organism can produce more than one 
toxin at the same time. These active products can be considered as part of survival strategies of the 
producers, as they constitute competitive advantages in the environment. It is not always 
straightforward to understand the benefit conferred by a certain toxin to a microorganism, but this can 
be mostly attributed to our limited knowledge about many ecologic, functional and evolutionary 
aspects of toxin-producing species. In fact, toxins can be considered evolutionary advantages, as they 
contribute to the survival and/or dominance of a particular organism in a particular environment. 
Microorganisms are recognized for their metabolic versatility and ability to produce diverse 
bioactive compounds such as hydrolytic enzymes, antibiotics, antitumorals and also toxins. Toxins can 
be produced by prokaryotes such as bacteria [1], in particular cyanobacteria [2], but also by eukaryotes 
such as dinoflagellates [3], diatoms [3], fungi (mycotoxins) [4,5], and animals (zootoxins or venoms) 
[1]. With such a broad range of producers, it is expected that toxins present high diversity in chemical 
composition and mode of action. 
The ubiquity of microorganisms in the environment makes them important causes of water and 
foodborne intoxications, representing central issues in food safety, public health and human and 
animal well-being. Many of these microorganisms may be present in drinking water supplies or 
recreational waters. Moreover, the toxins have also great economical impact due to their deleterious 
effects. Due to their importance, this review will focus on toxins produced by prokaryotic 
microorganisms in aquatic environments. Toxins 2010, 2  
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Toxins can have diverse natures, including small molecules, peptides, cyclic peptides, lipopeptides, 
alkaloids, carbamate alkaloids, organophosphates and proteins. Several hundreds of them are known 
and some have variants with different levels of toxicity. 
Toxins present different modes of action and cellular targets, resulting from the chemical nature of 
the toxin and from their interaction with the target cell. Classification of toxins is not a consensual 
subject: clinicians often arrange them by the organ they affect (hepatotoxin, neurotoxins, etc.), cell 
biologists prefer to group them according to their effect in the cell (mutagens or carcinogens) and 
biochemists refer to toxins by chemical origin (e.g., amino acids, peptides, lactones, etc). Other 
possible classification schemes can be defined based on the toxin mode of action, which may be 
considered a more wide-ranging criterion. Thus, a brief overview of their diversity will be presented 
based on the type of action that toxins play in the cell. 
Membrane permeabilization: These toxins start binding to the membrane in their monomeric form. 
Afterwards, self-oligomerization occurs resulting in the formation of pores that are permeable to ions 
and small metabolites. Ultimately, this leads to impaired membrane permeability, membrane 
disruption or osmotic lysis of the cell [6]. 
Toxins affecting membrane traffic: Some toxins can interfere with several components of   
vesicle-associated membrane protein system, altering the traffic of molecules like neurotransmitters 
across the membrane (e.g., botulinum toxin) [7,8]. 
Toxins affecting signal transduction: There are toxins that target the intestinal epithelial cells 
where, after a complex series of events, they activate adenylate cyclase, interfering with signal 
transduction (e.g., cholera toxin) [9]. Other natural toxins act by modifying key functions of the 
phosphorylation-based signaling machinery, thus affecting the signal transduction pathways   
(e.g., microcystins) [2].  
Toxins affecting protein synthesis: This group of toxins can present more than one mechanism to 
inhibit protein synthesis. Two examples are the cleavage of several nucleobases from the 28S rRNA 
(e.g., Shiga toxins) [10] or the inactivation of elongation factor 2 (eEF-2) by transferring the adenosine 
diphosphate ribose moiety (ADP-ribose) of NAD to eEF-2 (e.g., Pseudomonas exotoxin A) [11]. 
Cytoskeleton-affecting toxins: These toxins can induce structural changes in the cytoskeleton and 
consequently inhibit its functions. Cytoskeleton modifications include the disaggregation of actin 
microfilaments (e.g., Toxin B from Clostridium dificille) [12] or the induction of the formation of giant 
multinucleated cells, leading to changes in actin and tubulin organization (e.g., cytotoxic necrotizing 
factor of Escherichia coli) [13].  
Voltage-gated ions channels blockers: These toxins have the ability to interact with the specific 
receptors associated with neurotransmitter receptors, or with voltage-sensitive ion channels, therefore 
inhibiting the nervous signaling (e.g., saxitoxin, kalkitoxin and jamaicamides) [3,14].  
2. Toxins Produced by Cyanobacteria 
Some of the most common toxins present in water are produced by cyanobacterial strains of several 
species. Cyanobacteria represent one of the major bacterial phyla, being an ancient group of 
prokaryotic microorganisms exhibiting the general characteristics of gram-negative bacteria whose 
fossil registers date to 3.5 billion years [15,16]. Cyanobacteria constitute an extraordinarily diverse Toxins 2010, 2  
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group of prokaryotes. Due to their particular features, they have successfully colonized a wide range of 
habitats such as fresh, brackish and marine waters, nonacidic hot springs, hypersaline environments, 
Antarctic soils, rocks, ice and deserts [17–20]. Only pH seems to restrict the distribution of 
cyanobacteria, since they tend to prefer neutral or basic conditions and are less common at low 
pH [19]. They are unique among the prokaryotes, as they have the ability of performing oxygenic 
photosynthesis, being presumably the first oxygen-evolving photosynthetic organisms during the 
Precambrian era. They are thought to be also responsible for the transition of the atmosphere of the 
Earth from its primordial anaerobic state to the current aerobic condition [20]. 
2.1. Blooms and toxicity 
Cyanobacterial cell numbers in water bodies vary seasonally as a consequence of changes in water 
temperature and irradiance, as well as meteorological conditions and nutrient supply. Interactions 
among phytoplankton organisms in freshwater ecosystems have been detected through changes in the 
relative abundance of microalgae populations within the phytoplankton communities. In temperate 
regions, seasonal successions of organisms belonging to different phytoplankton taxa are often 
observed. Whereas at the beginning of summer a great variety of microalgae and cyanobacteria usually 
co-exist in the same water body, towards the end of summer this diversity may drop drastically as the 
result of the massive development of cyanobacterial communities (blooms). One the most known 
phenomena are the dense blooms of Trichodesmium erythraeum that produce a red discoloration of the 
water and gave the Red Sea its name [19]. Detrimental effects of such cyanobacterial blooms and toxin 
production are of major concern for water managers. They have become a worldwide increasing 
problem in aquatic habitats (lakes, rivers, estuaries, and oceans) and in man-made water storage 
reservoirs. These occurrences can be partially attributed to the gradual eutrophication of the 
waterways, exposure to constant sunshine, warmth and availability of nutrients like phosphates and 
nitrates [21]. For example, a low ratio between nitrogen and phosphorous concentrations is one 
important factor that seems to favor the development of cyanobacterial blooms  [18,22]. Since 
cyanobacteria possess maximum growth rates at temperatures higher than those of green algae and 
diatoms, the cyanobacterial blooms in temperate water bodies occur mostly during summer months 
[21,22]. However, there is an unpredictable nature in cyanobacterial blooms and the underlying factors 
that trigger these phenomena are still poorly understood. As a consequence, the erratic behavior of 
blooms, in respect to their occurrence, composition, intensity and persistency, demands careful 
attention in assessing risks for animal and human health. 
2.2. Importance and impact of the cyanotoxins occurring in aquatic environments 
One of the habitats where microorganisms are highly abundant is water. Since many of these 
microorganisms can produce toxins, they may have a great impact in several living organisms. Toxins 
produced by cyanobacteria and other microorganisms in sea, rivers, lakes and reservoirs can create 
adverse effects worldwide. These impact on health and wellbeing, because they are able to induce 
illness or even death. However, the toxins have also great economic impact due to their 
deleterious effects. Toxins 2010, 2  
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Contrarily to several other waterborne microbial and toxicant health hazards, which are 
undetectable to the human eye, cyanobacteria are often readily apparent to the human eye and 
sometimes olfaction. This is due to the water discoloration, formation of blooms and production of 
smelling compounds. Cyanobacterial toxic blooms create major threats to animal and human health, 
tourism, recreation and aquaculture (Figure 1). The occurrence of toxic mass populations appears to 
have a global distribution [2,23]. The first documented case of a lethal livestock intoxication occurred 
after consumption of water from a lake heavily populated with cyanobacteria. This was reported in a 
lake of the Murray River estuary (Australia) by Francis in the 1800s [24]. Nowadays, incidents 
including both human and animal intoxications have been reported around the world. Lethal animal 
cases include death of sheep, cattle, horses, pigs, dogs, fish, rodents, amphibians, waterfowl, bats, 
flamingos, zebras and rhinoceroses [23–32]. 
Aquatic recreational activities involving direct contact with contaminated water such as swimming, 
sailboarding, canoeing and paddling may lead to ingestion, aspiration/inhalation or skin contact with 
toxic cyanobacterial cells and/or with their toxins. There have been reports about the effects on 
exposed humans, including respiratory irritation, eye inflammation and severe contact dermatitis. The 
severity of these effects depends on the toxin dose exposure [23,33,34]. 
Figure 1. Routes for animal and human intoxication with cyanobacterial toxins.  
 
Although most reports of human intoxication caused by cyanobacteria are due to direct ingestion of 
contaminated water [35,36], chronic intoxication may occur by ingestion of food containing 
cyanobacterial toxins. For instance, it is known that several cyanobacterial toxins can be accumulated 
and transferred through the food chain. Microcystins can accumulate in mussels [37–39], fish and 
crustaceans [40], crayfish [41] and even plants that are irrigated with contaminated water [39,42]. 
Paralytic shellfish poisons (PSP) toxins can accumulate in cladoceran Daphnia magna [43], clams, 
crabs [39] and freshwater mussels [44,45]. Cylindrospermopsin accumulates in mussels [46]. 
However, there is no evidence of human intoxication risk via bioaccumulation in cattle fed, in neither 
milk nor beef [47]. 
So far, numerous bioactive metabolites produced by cyanobacteria have been described, including 
non-ribosomal peptides, lipopeptides, alkaloids and polyketides that present a vast diversity of 
structures and variants. Some of them are potent toxins [23,48–51]. The majority of these peptides are Toxins 2010, 2  
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assumed to be synthesized by NRPS (non-ribosomal peptide synthesis, involving peptide synthetases) 
or NRPS/PKS hybrid pathways, involving peptide synthetases (PS) and polyketide synthases 
(PKS) [52]. Non-ribosomal peptide synthetases (NRPSs) are multimodular enzymes, found in fungi, 
cyanobacteria and other bacteria, which biosynthesize peptides without the aid of ribosomes. This kind 
of biosynthesis allows reaching structures not possible to be obtained by ribosomal peptide synthesis. 
Most of the non-ribosomal peptides from microorganisms are classified as secondary metabolites, 
meaning that they do not have a role in primary metabolism, growth or reproduction, but have evolved 
to somehow benefit the organism that produces it. 
Since 2000, major efforts have been made to disclose the genetic basis of the biosynthesis of the 
compounds produced by cyanobacteria, some of them with unique structures. Here we overview the 
main gene clusters responsible for cyanotoxins biosynthesis; and discuss similarities and differences 
among them. 
Usually the toxins produced by cyanobacteria are classified according to the effect that they 
provoke in mammals and vertebrates, where hepatotoxins (liver damaging), cytotoxins 
(cell  damaging), neurotoxins (nerve damaging) and toxins responsible for allergenic reactions 
(dermatotoxins) have been isolated and characterized from several cyanobacteria [48]. A single species 
may contain toxic and non-toxic strains; therefore identification at the species level by microscopic 
morphology does not indicate the potential for toxin production of a given strain. Toxic variations, 
between and within species of cyanobacteria, are well known from laboratory studies based on isolated 
cultured strains [53–56]. So far, an organism able to produce all the variants of each type of toxins or 
all the types of cyanotoxins has not been described. However, there are some reports on 
Cylindrospermopsis raciborskii strains able to produce several toxins such as cylindrospermopsin, 
PSPs and unknown compounds [57,58], and also some cases of Microcystis strains able to produce 
microcystins and/or anatoxin-a [59]. 
2.3. Hepatotoxins 
2.3.1. Microcystins 
One of the most abundant types of cyanotoxins worldwide are microcystins (MC) and are 
consequently the more intensely studied. An increased incidence of primary liver cancer in China has 
been associated with the chronic ingestion of sublethal doses of microcystins in raw drinking 
water [23,60]. The direct uptake of water contaminated with these cyanotoxins through renal dialysis 
also resulted in some human deaths [36,61]. 
Microcystins are cyclic peptides with a molecular mass ranging from 900–1100 Da. They share a 
common structure constituted by Adda-D-Glu-Mdha-D-Ala-L-X-D-MeAsp-L-Z, where X and Z are 
variable L-amino acids, Adda is the unusual C20 amino acid (3-amino-9-methoxy-2,6,8-trimethyl-10-
phenyl-4,6-decadienoic acid), D-MeAsp is 3-methylaspartic acid, and Mdha is   
N-methyl-dehydroalanine [2]. About 80 different variants of microcystins have been described [23,62], 
with different levels of toxicity. The most common microcystins are MC-LR, MC-RR and MC-YR 
having the L-amino acids leucine (L), arginine (R) or tyrosine (Y), respectively, in the X position.  
MC-LR is the most studied variant because of its ubiquity, abundance and toxicity.  Toxins 2010, 2  
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MC are known to be produced by several cyanobacterial genera including Microcystis, 
Planktothrix,  Oscillatoria,  Anabaena,  Anabaenopsis,  Nostoc,  Hapalosiphon,  Snowella and 
Woronichinia [18,23,27,34]. 
The main target of MC is the hepatocyte, the most common cell type in the liver. MC inhibit 
eukaryotic protein phosphatases and also activate the enzyme phosphorylase b, which results in an 
excessive phosphorylation of cytoskeletal filaments triggering apoptosis [63]. Death of hepatocytes 
leads to the destruction of the finer blood vessels of the liver and to massive hepatic bleeding. Some 
in vivo and in vitro studies show that organs like kidney and colon can also be affect by the exposure 
of humans to these toxins [64].  
MC cannot diffuse through the plasma membrane because of their high molecular weight and 
structure. However, cell specificity and organotropism of MC-LR suggested that a selective pathway 
for MC uptake would probably exist. Several studies point to the intake of MC through the plasma 
membrane by a member of the organic anion transporting polypeptide superfamily (OATP)   
(Figure 2) [64]. 
Concerning the molecular mechanism of MC toxicity, it is a multi-pathway process, in which the 
inhibition of serine/threonine protein phosphatases type 1 and type 2A (PP1/PP2A) leads to a cascade 
of events responsible for the MC cytotoxic and genotoxic effects in animal cells (Figure 2). The 
mechanisms of tumor promotion are unclear, but apparently they are related to protein phosphatase 
inhibition leading to hyperphosphorylation of many cellular proteins and deregulation of cell-cycle 
control. Cell-cycle progression is largely controlled by reversible phosphorylation of regulatory 
enzymes on their serine/threonine residues. Accordingly, it has been proposed that microcystin induces 
an increase of oxidative stress, leading to a raise of reactive oxygen species, which can cause DNA 
damage and is associated with microcystin-induced liver carcinogenesis. In fact, in vitro and in vivo 
studies have found oxidative DNA damage in the form of 8-oxo-7,8 dihydro 2’-deoxyguanosine 
associated with microcystin exposure [65].  
Through the inhibition of PP1 and PP2A, MC seems to control several cellular processes,   
e.g., activation of the calcium-calmodulin-dependent multifunctional protein kinase II (CaMKII) by 
inhibiting its dephosphorylation. The activation of CaMKII may further regulate downstream events 
such as ROS formation and phosphorylation of proteins including myosin light chain [66]. MC-LR can 
also activate Nek2 kinase by binding to Nek2 kinase complex with PP1 holoenzyme [67]. Nek2 kinase 
is a member of the NIMA-related serine/threonine kinase family that participates in the control of 
mitotic progression and chromosome segregation. This interaction may have implications in the cell 
viability, tissue injury and tumor development [64]. Moreover, mitogen-activated protein kinases 
(MAPKs) are serine/threonine-specific protein kinases that regulate several cellular activities, such as 
proto-oncogenes expression, mitosis, differentiation, proliferation, and cell survival/apoptosis. PP2A 
mediates MAPKs expression. Therefore the presence of MC probably regulates MAPKs expression 
as well [68]. 
MC genotoxicity is also associated with its ability to inhibit two DNA repair systems: nucleotide 
excision repair (NER) and DNA double strand break (DSB) repair by the nonhomologous end joining 
(NHEJ). Both systems are regulated by phosphorylation and the inhibition of PP1/PP2A significantly 
decreases their activity. Furthermore, the inhibition of the DSB-NHEJ pathway is a consequence of 
loss of activity of the DNA-dependent protein kinase (DNA-PK) resultant from its phosphorylation, Toxins 2010, 2  
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after the inhibition of PP2A like enzymes [64]. Additionally, an increase in serine phosphorylation of 
the nuclear phosphoprotein P53 was identified following both lethal and sublethal MC-LR exposure in 
mice [69]. This protein is a substrate of PP2A and plays a role as a transcriptional trans-activator in 
DNA repair, apoptosis and tumor suppression pathways [64]. P53 is also a regulator of the expression 
of the anti and proapoptotic genes including members of the Bcl-2 family such as Bax and Bid. Bax 
and Bid, play important roles in apoptosis, especially in mitochondria-dependent pathway. Studies 
indicate that MC-LR can induce mitochondria-dependent apoptosis via the regulation of Bcl-2 family 
members [70] (Figure 2). 
The role of ROS and related mechanisms in MC-LR-induced liver injury in vivo are not completely 
understood. Two possible pathways are mentioned; one of them concerns the outer-membrane 
permeabilization of the mitochondria after a MC induced massive Ca
2+ influx, thereby triggering the 
process of apoptosis. Another plausible mechanism for ROS generation is the increase of NADPH 
oxidase activity [64] (Figure 2). 
Besides what is here presented, there is still much to be done to completely unveil the molecular 
mechanisms of MC toxicity.  
Figure 2. Schematic representation of the molecular mechanisms of microcystins (MC) 
toxicity. After intake through the plasma membrane by the organic anion transporting 
polypeptide system (OATP), MC binds specifically to the serine/threonine protein 
phosphatases (PP1/PP2A), inhibiting them and leading to a cascade of events responsible 
for the MC cytotoxic and genotoxic effects in animal cells (see text for details). 
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Microcystins are produced non-ribosomally via a thio-template mechanism, by a multienzyme 
complex consisting of peptide synthetases (PS), polyketide synthases (PKS) and tailoring enzymes. 
The gene cluster for microcystin biosynthesis was the first to be completely sequenced from a 
cyanobacterium. It contains approximately 55 kb and is one of the largest bacterial gene clusters 
described so far. This cluster has been identified and sequenced in three phylogenetic distantly related 
strains,  Microcystis aeruginosa PCC 7806 [71], Planktothrix agardhii CYA 126 [72] and 
Anabaena sp. strain 90 [73]. Its schematic representation is displayed in Figure 3. This gene cluster 
consists of nine (Planktothrix) or ten (Microcystis and Anabaena) open reading frames (ORFs). In 
each module there are specific domains for activation (aminoacyl adenylation domain) and 
thioesterification (peptide carrier domain) of the amino acid substrate and for elongation (condensation 
domain) of the growing peptide that is being assembled [71]. The organization of the genes clearly 
differs among genera. In Microcystis and Anabaena, the genes are transcribed from a central 
bidirectional promoter region, whereas in Planktothrix all mcy genes except mcyT seem to be 
transcribed unidirectionally from a promoter located upstream of gene mcyD [74]. However, the 
multienzyme components are highly similar in the different genera. Except for the tailoring enzymes 
mcyI, mcyF and mcyT, all other genes mcyABCDEGH are always present. However, only the mcyA-C 
arrangement appears to be fairly conserved among toxic strains of the different genera. The mcyH gene 
is an ABC-transporter-like gene and it is thought to be involved in the transport of microcystin [75]. It 
is assumed that this transporter may be responsible for the localization of the toxin in 
thylakoids [76,77] or for its extrusion under certain growth conditions [78]. 
2.3.2. Nodularin 
Nodularin is a pentapeptide with a molecular mass of 824 Da. Comparison with microcystin shows 
the presence of N-methyl-dehydrobutyrine (Mdhb) instead of Mdha, and the lack of D-Ala and 
X residues. So far, this toxin has only been found in Nodularia spumigena [2]. 
Like microcystins, nodularin is a potent tumor promoter that may also act as a carcinogen/tumor 
initiator and inhibits serine/threonine protein phosphatase-1 and 2A. However, it does not covalently 
bind to PP1 or PP2A [79]. Due to its structural similarity with microcystins, nodularin is expected to 
present molecular mechanisms of toxicity similar to those of MC (Figure 2). 
A mcy homologous gene cluster (nda) described in Nodularia spumigena NSOR10 is considered 
responsible for the synthesis of the pentapeptide nodularin [80]. The 48 kb region of the genome 
consists of nine ORFs (ndaA-I) as depicted in Figure 3. Functional assignment of the enzymes was 
based on bioinformatic analysis and homology to microcystin synthetase enzymes. The nda cluster 
also encodes several putative monofunctional enzymes that may have a role in the modification (NdaE 
and NdaG) and transport (NdaI) of nodularin. 
Studies that have been conducted on the detection and regulation of the genes that are involved in 
hepatotoxins production are beyond the present scope of this review. The interested reader should see 
recent reviews [74,81]. 
 Toxins 2010, 2  
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Figure 3. Schematic representation of the  organization of cyanobacterial gene clusters responsible for the biosynthesis of hepatotoxins 
(microcystins, nodularin, cylindrospermopsin). Different ORFs are indicated as arrows and domains integrated within proteins as circles. 
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2.4. Cytotoxins: cylindrospermopsin 
Cylindrospermopsin (CYN) is also the object of several studies due its impact, namely in Australia. 
It is a potent alkaloid, with a molecular mass of 415 Da, consisting of a tricyclic guanidine moiety 
combined with hydroxymethyluracil. In contrast to MC, the structural variability is much lower. So 
far, only three variants of the cylindrospermopsin molecule have been described, including   
deoxy-cylindrospermopsin and 7-epi-cylindrospermopsin, with CYN being more toxic than   
deoxy-cylindrospermopsin. The presence of guanidino and sulfate groups makes CYN a zwitterionic 
molecule and hence more soluble in water. Moreover, being a small compound, it is likely to be taken 
by the cells through diffusion. 
CYN and its analogues are known to be produced by some cyanobacterial species, namely, 
Cylindrospermopsis raciborskii [82–84], Umezakia natans [85], Aphanizomenon ovalisporum [86], 
Raphidiopsis curvata [87], Anabaena bergii [88], and more recently Aphanizomenon flos-aquae [89] 
and Lyngbya wollei [90]. 
Terao et al. [91] described the liver as the main target of this cyanotoxin but other histopathological 
studies showed that kidneys, thymus and heart are also affected [92,93]. The first clinical symptoms of 
CYN ingestion are kidney and liver failure [34].  
CYN toxicity results in four pathological changes in the liver: protein synthesis inhibition, 
membrane proliferation, fat droplet accumulation, and cell death. Despite extensive research, the 
specific molecular interactions that result in CYN-mediated toxicity are currently unknown. However, 
it is recognized that this toxin is genotoxic, hepatotoxic in vivo and is also a general cytotoxin that 
blocks protein synthesis. Its toxicity is due to the inhibition of glutathione (GSH) and protein synthesis 
as well as the inhibition of cytochrome P450 (CYP450) (Figure 4) [94]. There is also evidence of its 
carcinogenic potential in mice [95]. GSH seems to be required to inactivate cylindrospermopsin, but in 
the presence of CYN, GSH synthesis is inhibited in the hepatocytes [96]. 
CYN can also covalently bind to DNA and there is evidence that CYN causes DNA breakage [97]. 
Therefore, mutagenic activity of the toxin can also be expected. Nevertheless, the exact mode by 
which CYN causes DNA damage has yet to be determined. 
The disclosure of the genes responsible for the biosynthesis of cylindrospermopsin began with 
Schembri et al. [88]. They showed a direct link between the presence of polyketide synthases (PKS) 
and peptide synthetases (PS) genes in C. raciborskii isolates and the ability of those isolates to produce 
cylindrospermopsin. Later on, Shalev-Alon et al. [98] identified amidinotransferase genes (AoaA, 
AoaB, and AoaC) in an Aphanizomenon ovalisporum strain that could be implicated in the 
cylindrospermopsin synthesis. Recently, using adaptor-mediated gene walking technology, a 
polyketide biosynthetic pathway, thought to be responsible for the production of cylindrospermopsin, 
has been described in C. raciborskii [94,99]. This cluster spans 43 kb and most of the allocated genes 
are of PKS nature (Figure 3). However, the biochemical proof for the role of this gene cluster in 
cylindrospermopsin biosynthesis is still lacking, mostly due to the absence of suitable tools for genetic 
transformation of Cylindrospermopsis. Toxins 2010, 2  
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Figure 4. Schematic representation of the known molecular mechanisms involved in 
Cylindrospermopsin (CYN) toxicity. There is inhibition of glutathione (GSH) and protein 
synthesis, as well as cytochrome P450 (CYP450), and CYN interaction with DNA. 
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2.5. Neurotoxins 
2.5.1. Anatoxin-a and homoanatoxin-a 
Anatoxin-a and homoanatoxin-a are unusual alkaloids, secondary amines, with low molecular 
masses (165 and 179 Da, respectively) exclusively produced by cyanobacteria. 
Anatoxin-a is synthesized by various members of the genera Anabaena [92], Cylindrospermum [100], 
Microcystis [59], Oscillatoria [100], Raphidiopsis [101], Planktothix [102] and Aphanizomenon [103]. 
Homoanatoxin-a is produced by species of the genera Oscillatoria [104], Anabaena [105], 
Raphidiopsis [101] and Phormidium [32]. Some strains are able to produce simultaneously anatoxin-a 
and homoanatoxin-a [101,106].  
Anatoxin-a, also previously known as “Very Fast Death Factor”, acts as a post-synaptic 
neuromuscular blocking agent. Anatoxin-a and homoanatoxin-a are potent agonists of the muscular 
and neuronal nicotinic acetylcholine receptor. The toxin irreversible binding to the nicotinic 
acetylcholine receptor causes sodium channel opening and a constant inflow of sodium ions to cells 
(Figure 5). Overstimulation of the muscle cells occurs as a result of membrane depolarization and 
desensitization. When respiratory muscles are affected, the lack of oxygen in the brain may lead to 
convulsions and finally to death of animals by acute asphyxia [47]. Toxins 2010, 2  
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Figure 5. Schematic representation of Anatoxin-a/Homoanatoxin-a and Anatoxin-a(s) 
molecular mechanisms of toxicity. During “normal events” acetylcholine is released from 
the neurons, binds to the acetylcholine-receptors on the postsynaptic muscle cell thereby 
inducing the influx of Na
+ into the cell. Acetylcholine is degraded by the enzyme 
acetylcholinesterase in the synaptic cleft into acetate, which is eliminated, and cholin, 
which is taken up into the neuron by specific carriers. However, in the presence of 
anatoxin-a and homoanatoxin-a, these toxins bind irreversibly to the nicotinic acetylcholine 
receptor causing sodium channel opening and the constant inflow of sodium ions to cells. 
Anatoxin-a(s) causes an irreversible inhibition of the acetylcholinesterase preventing 
degradation of acetylcholine. The muscles become constantly stimulated. 
 
In 2009, the efforts of Cadel-Six et al. and Méjean et al. showed evidence linking the presence of a 
29 kb DNA fragment containing polyketide synthases and the production of anatoxin-a and 
homoanatoxin-a (Figure 6) [107,108]. The sequence of the gene cluster, assumed to be involved in the 
production of these toxins, was also obtained by adaptor-mediated gene walking technology. The 
function of the several identified ORFs was deduced by comparison with other annotated genes and, to 
date, attempts to genetically confirm the role of this gene cluster in the biosynthesis of these toxins by 
specific gene disruption have been unsuccessful. Toxins 2010, 2  
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Figure 6. Schematic representation of the  organization of cyanobacterial gene clusters responsible for the biosynthesis of neurotoxins 
(anatoxin-a and homoanatoxin-a, saxitoxin, jamaicamide), curacin A and barbamide. Different ORFs are indicated as arrows and domains 
integrated within proteins as circles. 
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2.5.2. Anatoxin-a(s) 
Anatoxin-a(s) is a unique organophosphate with a molecular mass of 252 Da. It is synthesized by 
Anabaena flos-aquae [109] and Anabaena lemmermanni [29]. 
This toxin causes an irreversible inhibition of acetylcholinesterase, which consequently cannot 
perform the degradation of acetylcholine that is bound to the acetylcholine-receptor [109]. As a result, 
muscles become constantly stimulated [110] (Figure 5). Its functional consequences are comparable to 
the one of organophosphorous and carbamate insecticides like paraoxon, physostigmine, 
pyridostigmine [111] and the chemical warfare agent sarin [112]. 
2.5.3. Saxitoxin 
Saxitoxins (STX), commonly known has paralytic shellfish poisons (PSPs), are tricyclic 
perhydropurine alkaloids that have a molecular mass of 299 Da. They can be non-sulfated   
(saxitoxins and neosaxitoxin), single sulfated (gonyautoxins) or doubly sulfated (C-toxins) and the 
possible substitutions at various positions of the molecule results in more than 30 structural 
variants  [2,113,114]. The toxicity of the STX derivatives is different and depends on the type of 
variant produced; saxitoxin (STX), neosaxitoxin (NEO), and gonyautoxins (GTX1-4) are the most 
toxic molecules. 
Saxitoxins are produced by marine dinoflagellates and cyanobacteria. Members of the freshwater 
cyanobacteria genera Anabaena, Aphanizomenon, Cylindrospermopsis, Lyngbya and Planktothrix are 
able to produce these kinds of toxins [14].  
Saxitoxin binds to the sodium and calcium channels of the nerve axon membranes, preventing the 
passage of these ions through the cell membrane and therefore blocking the transfer of the nerve 
impulse [115,116] (Figure 7). It also extends the gating of potassium channels in heart cells [117]. This 
action results in a disturbance in the propagation of action potential to muscle cells. Depending on the 
dose, saxitoxin poisoning may cause symptoms such as tingling and numbness around the lips or, in 
extreme situations, neuromuscular paralysis and death caused by respiratory failure. It has also been 
shown to exhibit a cardio depressant effect [118]. 
Figure 7. Schematic representation of saxitoxin toxicity mechanism. Saxitoxin binds to the 
sodium or calcium channels of the nerve axon membranes, preventing the passage of these 
ions through the cell membrane thus blocking the transfer of the nerve impulse. 
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Saxitoxins are among the most toxic compounds known. Nowadays, saxitoxins are already included 
in the Schedule 1 of the Chemical Weapons Convention together with warfare agents such as mustard 
gas, sarin, ricin and others [118,119]. 
In 2008, Kellman et al. revealed the biosynthetic pathway of STX production using reverse genetics 
to identify the candidate STX biosynthetic gene cluster (sxt) in the cyanobacterium 
Cylindrospermopsis raciborskii T3 [120]. Functional assignment of the enzymes was based on 
bioinformatic analysis combined with the liquid chromatography-tandem mass spectrometry analysis 
of the biosynthetic intermediates; however, the biochemical proof for the role of this gene cluster in 
saxitoxin biosynthesis is lacking, because C. raciborskii is not genetically transformable. In 
C. raciborskii, the sxt gene cluster spans approximately 35 kb and presents genes responsible for toxin 
biosynthesis, regulation and export (Figure 6). However, some of the identified genes have not yet 
been assigned to a function due to their low level of homology with proteins present in databases. 
Later on, in order to obtain the sequences of the gene cluster also responsible for SXT biosynthesis 
in Anabaena and Aphanizomenon, a gene walking technique (pan-handle PCR) was employed by 
Mihali et al. [114]. It revealed a 29 kb gene cluster in Anabaena circinalis, and a slightly smaller 
cluster in Aphanizomenon of 27.5 kb (Figure 6). The bioinformatically-deduced functions reveal that 
the cluster presents some variations between the genera, namely in the genes assumed to be involved 
in toxin regulation, and there are also some differences regarding the genes supposedly involved in 
toxin transport. 
2.6. Lipopeptides from marine cyanobacteria 
Marine cyanobacteria are amazing in the diversity of new biologically active natural products 
synthesized using mixed NRPS/PKS systems. Several lipopeptides have been purified from the marine 
cyanobacteria  Lyngbya majuscula. For example, Kalkitoxin and jamaicamides A, B, and C are 
neurotoxins that block voltage-gated sodium channels, while antillatoxins A and B activate them [14]. 
Metabolites with pharmacological importance, like barbamide (used in the biological control of snails), 
the anticancer compound curacin A and antifungal agents as hectochlorin, have also been identified. 
2.6.1. Jamaicamides 
Jamaicamide A is a highly functionalized lipopeptide containing an alkynyl bromide, vinyl 
chloride, -methoxy eneone system, and pyrrolinone ring. Jamaicamide B is a debromo analogue of 
jamaicamide A, while in jamaicamide C, which also lacks the bromine atom, a terminal olefin replaces 
the terminal alkyne of jamaicamide B. Jamaicamides A, B and C have all been isolated from 
Lyngbya majuscula. 
Jamaicamides have been demonstrated to present a sodium channel blocking activity (Figure 7) and 
fish toxicity. 
The biosynthetic pathway responsible for jamaicamides synthesis has been recently 
investigated  [121]. Based on feeding precursor experiments to jamaicamide-producing cultures, an 
effective cloning strategy for the biosynthetic gene cluster discovery was developed. The 58 kb gene 
cluster has 17 open reading frames (Figure 6), the majority of PKS nature, showing a notable co-linear 
arrangement with respect to its proposed utilization during biosynthesis [121].  Toxins 2010, 2  
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2.6.2. Kalkitoxin 
Kalkitoxin is a thiazoline-containing lipid derivative also produced by the pantropical marine 
cyanobacterium Lyngbya majuscula.  
It has been indirectly shown that kalkitoxin blocks voltage-gated sodium channels (Figure 7) [122]. 
Furthermore, this toxin has proven to be ichthyotoxic to the goldfish Carassius auratus and toxic to 
the crustacean brine shrimp Artemia salina [123]. 
2.6.3. Antillatoxins 
An extremely potent ichthyotoxic L. majuscula metabolite, antillatoxin A, was firstly reported in 
1995 [124]. Antillatoxin is a structurally remarkable lipopeptide, presenting a high degree of 
methylation. It is among the most ichthyotoxic metabolites isolated, and is only exceeded in potency 
by the brevetoxins [124]. 
The studies performed so far to determine its mechanism of action showed that it activates the 
mammalian voltage-gated sodium channel at a pharmacological site that is distinct from any 
previously described [125]. Antillatoxin B is a variant of antillatoxin A, which has reduced sodium 
channel-activation properties and exhibits less ichthyotoxic activity [126]. 
2.6.4. Curacin A 
Curacin A is a unique natural product presenting a structure with two lipid chains and sequential 
thiazoline and cyclopropyl rings. 
Curacin is promising as an antiproliferative agent due to its inhibitory action on tubulin 
polymerization. Since it has been shown to block cell cycle progression by interacting with the 
colchicines binding site on tubulin and inhibiting microtubule polymerization, this compound may 
have value in the treatment of neoplasic disorders [127]. 
The genetic basis involved in curacin production has been described by Chang et al. [128]. A 
combined approach employing isotope incorporation and molecular genetics was employed to reveal 
the biosynthetic pathway of curacin. The bioinformatic analysis showed that this gene cluster spans 
63.7 kb, containing 14 ORFs (Figure 6), making this the largest gene cluster described in 
cyanobacteria. The genetic architecture of the cluster shows a co-linear arrangement with respect to its 
expected utilization during biosynthesis. This amazing cluster is almost only composed by PKS 
modules, with the exception of curF, which is a hybrid PKS/NRPS bimodule. 
2.6.5. Barbamide 
Barbamide is a chlorinated lipopeptide that has been isolated due to its molluscicidal activity [129]. 
The biosynthetic pathway responsible for this toxin production has started to be revealed based on 
incorporation studies using isotope-labeled precursors. In 2002, Chang et al. have described the 
complete sequence of this unusual gene cluster containing NRPS and PKS modules [130]. Sequence 
comparison with databases showed the existence of 12 putative ORFs allocated in the 26 kb cluster 
(Figure 6). However, clear evidence of the involvement of each ORF of this gene cluster in barbamide 
biosynthesis will only be achieved by performing heterologous expression or gene disruption assays. Toxins 2010, 2  
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In this review, the diversity of the NRPS or NRPS/PKS hybrid pathways, involving peptide 
synthetases and polyketide synthases used by cyanobacteria to produce toxins with unusual structures 
(Figure 3 and 6), is shown. Most of the toxins (microcystins, nodularin, cylindrospermopsin, 
jamaicamide, curacin A and barbamide) have two main modular biosynthetic systems: (i) the   
non-ribosomal peptide synthetases (NRPSs), responsible for assembling amino acids leading to peptide 
formation, and (ii) the polyketide synthases (PKSs), used to link together acetate as the primary 
building block. Since NRPS and PKS enzymes are able to accept a wide range of different substrates, a 
huge number of possible different structures can be reached using these systems. 
In NRPS, a minimal elongation module, that is responsible for one elongation step, comprises three 
catalytic domains: an adenylation domain (A), responsible for substrate recognition and activation by 
adenylation; a thiolation domain (T), needed for the covalent incorporation as thioesters; and one 
condensation (C) domain, for condensation of the precursor [131] (e.g., P. agardhii mcyB gene in 
Figure 3). Epimerization (E) or N-methylation (NMT) domains may also be present in the module, 
leading to further substrate modification (P. agardhii mcyA gene in Figure 3). 
The cyanobacterial PKS consists of multiple sets of domains and modules, which normally 
correspond to the number of acyl units in the product [132]. One module comprises a set of domains 
that are responsible for the activation, modification and elongation of a single amino acid or carbon 
unit. A minimal multifunctional module is composed of a ketoacyl synthase (KS) domain, an 
acyltransferase (AT) domain and an acyl carrier protein (ACP) domain (e.g., the cyrF gene of 
C. raciborskii cylindrospermopsin cluster). Frequently, ketoreductase (KR), dehydratase (DH) and 
enoyl reductase (ER) domains are constituents of megasynthases, as the anaE gene of Oscillatoria 
anatoxin-a and homoanatoxin-a cluster. 
In the case of the neurotoxins clusters, namely saxitoxin, an extraordinary number of secondary 
tailoring manipulations, including oxidation, methylation and diverse forms of halogenations are 
also present. 
With the exception of the Lyngbya majuscula clusters, all the other described clusters include ORFs 
responsible for the toxin transport (red arrows in Figure 3 and Figure 6). This evidence indicates that 
the release of the cyanobacterial toxins to water does not necessary implies cell lysis, since some 
toxins may be actively exported from the cells. 
Another interesting feature of cylindrospermopsin, anatoxin-a/homoanatoxin-a and saxitoxin gene 
clusters is the presence of ORFs correspondent to transposases, which can lead to speculation that the 
presence of these transposases may have an important role in the horizontal transfer of these genes. 
2.7. Lipopolysaccharides 
Endotoxic lipopolysaccharides (LPS) are part of the outer membrane of gram-negative bacteria, 
including cyanobacteria. LPS and its effects are well known from bacteria such as Escherichia coli, 
Salmonella spp., Vibrio cholera,  Yersina pestis and Pseudomonas aeruginosa. LPS composition 
includes lipid A, core polysaccharides and an outer polysaccharide chain. Opposing to the other 
bacteria, LPS from cyanobacteria have a higher diversity of long chain unsaturated fatty acids, 
hydroxyl fatty acids and lack phosphate [39]. Toxins 2010, 2  
 
 
2377
It is accepted that LPS cause fever in mammals and are involved in septic shock syndrome [133]. 
Besides their action on the immune system, LPS from bacteria and cyanobacterial origin also affect the 
detoxication system of different organisms [39]. However, LPS from bacterial origins have shown to 
be more toxic than the cyanobacterial ones. 
3. Toxins Produced by Other Bacteria in Aquatic Environments 
Although cyanobacteria are the most important group of aquatic toxigenic prokaryotes, there are 
other bacteria, present in aquatic environments, which can produce toxins with high relevance for 
human and animal health. Vibrio spp. are one of the most representative groups of aquatic toxin 
producers, commonly associated with seafood-born infections and intoxications. 
Aeromonas hydrophila is also associated with aquatic habitats and has been described as responsible 
for the production of toxins [134]. Furthermore, recognized pathogens like Escherichia coli, 
Campylobacter spp. or Legionella pneumophila are also water contaminants and have been described 
as emergent toxin producers. An overview about several aspects of these water associated toxin 
producers will be presented, including the diversity of toxins, their impact on environment and human 
life, molecular mechanisms, cellular consequences, pathways and genes involved in their biosynthesis.  
The diversity of bacterial toxins is high and more potentially toxic molecules are emerging. In this 
review we will focus on some representative examples, chosen based on the specificity of their 
molecular mechanisms and their impact on human and animal life. 
3.1. Vibrio spp. 
Vibrio species belong to Gamma-proteobacteria, are curved usually motile rods, mesophilic and 
presenting a chemoorganotrophic or facultative fermentative metabolism [135]. They are highly 
abundant in aquatic environments, including estuaries, marine coastal waters and aquaculture 
facilities  [136–139]. They also appear to be highly associated with marine organisms like 
fish  [140,141], mollusks [142,143] and shrimps [144,145], which are important food products for 
human consumption. Vibrio organisms present another important feature: they can attach to the 
exoskeletons of crustaceans and other marine organisms of the zooplankton, producing biofilms [137]. 
Their close relationship with zooplankton can be a survival strategy to resist to environmental stresses 
like starvation or antibiotic presence [146]. This strong association to zooplankton is of utmost 
importance, as they can easily enter into the human and animal food webs. On the other hand, some 
Vibrio species are recognized as relevant pathogens for animals reared in aquaculture [147,148]. Fish 
and shellfish mortality caused by vibrios is very frequent in early larval stages [149,150]. Sometimes 
Vibrio spp. infections can lead to the death of entire populations, with high economical consequences. 
Three Vibrio species (Vibrio cholerae, Vibrio parahaemolyticus and Vibrio vulnificus) are considered 
serious human pathogens. Both V. cholerae and V. vulnificus produce toxins that are fundamental as 
virulence factors. Some of the most relevant toxins produced by these species will be addressed in 
more detail. Toxins 2010, 2  
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3.1.1. Vibrio cholerae 
This species is the causative agent of cholera, a severe disease that had a central role in the history of 
infectious diseases. Cholera outbreaks are reported since 1817. Presently, Cholera continues to be 
responsible for thousands of deaths, especially in developing countries, where poor water supply and 
poor sanitation are unsolved problems [151,152]. V. cholerae is found in coastal, estuarine and marine 
environments, often associated with aquatic fauna such as copepods and shellfish and is transmitted to 
humans by contaminated water and food [151,152]. Close relationships with zooplankton are also 
established and cholera outbreaks have been associated with planktonic blooms and sea surface 
temperatures. The wide ecological relationships of V. cholerae, the ability to form biofilms and to adapt 
to environmental changes have highlighted the pathogenic potential of this species. 
The main virulence factor associated to V. cholerae pathogenesis is the production of the potent 
cholera toxin (CT). Cholera is characterized by a voluminous watery diarrhea, leading to rapid 
dehydration. Patients can lose as much as 20 liters of fluid in 24 hours and more than 50% of them die 
if not treated. The clinical aspects of the disease are primarily induced by the activity of this 
toxin [151], but not all strains are able to produce it. In fact, more than 200 V. cholerae serotypes have 
been described, but only two (O1 and O139) can produce the CT-toxin [151,153]. 
The genes for toxin synthesis (ctxAB) are carried by the lysogenic bacteriophage CTX and only 
strains with the integrated phage are able to produce CT-toxin [154]. The expression of these genes is 
coordinated with the expression of other virulence factors like TCP (toxin-coregulated pilus, coded by 
tcp genes and required for intestinal colonization) and the accessory colonization factors (coded by the 
acjA–D genes). Virulence genes are located in a pathogenicity island of V. cholera genome [151]. The 
primary direct activator of virulence genes transcription (including ctxABC) is ToxT protein. It 
belongs to a large protein family (AraC/XylS) that shares a domain of 100 amino-acids, which 
corresponds to a helix-turn-helix DNA binding motif and has transcription activation functions [155]. 
AraC domain is nearly invariant among all ToxT sequences, but a second domain (NTD) was 
identified in these proteins, being much less conserved. Its function is not clear, but it is thought that 
this domain is the binding site for a natural effector, which is proposed to be bile [156,157]. ToxT 
activates transcription by binding to a degenerate 13-bp DNA sequence (the toxboxes), located 
upstream of all genes activated by this protein. These toxboxes can occur in different configurations at 
different promoters and can be organized as direct or inverted repeats, never overlapping the -35 
promoter element [158]. The activity of ToxT in ctxAB promoter is mainly to counteract the H-NS 
histone-like protein that binds to the same region, but strongly represses the ctxAB gene expression. 
ToxT also interacts directly with the  subunit of RNA polymerase, activating transcription [159]. The 
regulatory pathways of CT toxin are complex, involving upstream regulation of toxT expression 
(regulatory proteins as ToxR, TcpP and ToxS have already been identified and characterized), 
interaction with effectors and coordination with the expression of other virulence genes. The 
regulatory pathways of CT production and expression of other virulence factors were recently 
reviewed by Matson et al. [151].  
After entry in the intestinal lumen, V. cholera interacts with intestinal microenvironment, sensing a 
luminal factor that induces a low expression level of TCP and enables the adherence of the bacteria to 
the intestinal mucosa, probably to the glycocalyx. A second environmental signal, dependent on Toxins 2010, 2  
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microbial adherence to the mucosa, is detected and enhances the level of TCP expression, promoting 
the intestinal colonization and finally inducing the production and secretion of CT toxin [160,161]. 
ToxR and TcpP, both inner membrane proteins, are critical for these events but the nature of the 
signals that activate them remain unclear.  
CT-toxin is a bipartite molecule belonging to the AB5 family, which also includes Shiga and 
pertussis toxins. CT combines one A active subunit and five identical peptides (~11 kDa) that is 
assembled into a highly stable pentameric ring named B subunit (~55 kDa). The A subunit presents 
two domains: A1 and A2. These two peptides are linked by an exposed loop containing a   
protease-sensitive “nick” site and a single disulfide bond.  
The B subunit has a high affinity to the oligosaccharide domain of the GM1 ganglioside on the 
surface of the intestinal epithelial cells, allowing the binding of the toxin to the plasma membrane of 
host cells. B pentamer binds stoichiometrically to five GM1 gangliosides at cell surface [161]. GM1 
functions to concentrate CT in glycolipid-rich apical microdomains (“lipid rafts”) located in the cell 
surface [162]. These lipid rafts are distinct cholesterol rich membrane structures that act as membrane 
organizing centers for signal transduction, protein and lipid sorting, endocytosis and transcytosis. The 
raft structure and role depends on the specific lipids that compose the microdomain and the specific 
binding of the toxin to GM1 gangliosides depends on these lipids. This step is considered to be the 
critical step for the subsequent targeting of the toxin into all intracellular compartments, required to 
trigger the cellular response. A stable binding between B subunit and GM1-receptor complexes is 
essential for CT function.  
Considering the A subunit, the A2 peptide (~5 kDa) attaches the A1 peptide (~22 kDa) to the B 
subunit and presents a COOH-terminal KDEL motif that extends from B pentamer on the side that 
binds GM1 [163]. This KDEL motif is known to be a sorting signal that allows endogenous proteins 
from endoplasmic reticulum (ER) to be retrieved efficiently from post-ER compartments. A1 is the 
enzymatic active subunit of the toxin and must dissociate from B subunit and translocate across a 
cellular membrane to act on its cellular target. 
CT is not a pore forming toxin. Rather it uses the host cell membrane traffic machinery, entering 
into the intestinal cell through a complex mechanism. The proposed pathway (Figure 8) starts with the 
binding of CT holotoxin to GM1 in the apical membrane. The GM1-CT complex enters the cell by apical 
endocytosis and traffics retrograde through Golgi cisternae into the ER lumen. Then A1 peptide 
unfolds, is translocated to the cytosol, and breaks away from the membrane after translocation. Then it 
can move by diffusion to its cellular target (adenylate cyclase complex), located on the cytoplasmatic 
surface of the basolateral membrane. Alternatively, the active subunit of the toxin can remain 
membrane associated. In this case, it moves back out of secretory pathway into the cytosol by vesicular 
transport back [162]. The B subunit does not translocate across cell membranes, remaining membrane 
associated (probably bound to GM1 receptors) and moving back out of the secretory pathway by 
vesicular traffic to the cell surface. This mechanism allows B subunit to move from its original binding 
site (apical/mucosal) to the basolateral site (basolateral/serosal) through Golgi cisternae and ER.  
The cellular target of CT is the adenylate cyclase complex at the basolateral membrane. The active 
subunit A1 acts as an enzyme that is able to specifically transfer ADP-ribose group to an arginine 
residue of the  subunit of the GTP-binding protein Gs. Once activated, this Gs  subunit dissociates 
from the Gs membrane-bound subunit and crosses the cell to attach to the catalytic unit of adenylate Toxins 2010, 2  
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cyclase in the basolateral membrane. Once activated, this enzyme induces the formation of cAMP and 
the subsequent activation of cAMP-dependent protein kinase. Finally, the phosphorylation of 
membrane proteins involved in the transepithelial ion transfer induces changes in the ion transport. 
The final consequences of this process are the inhibition of Na
+ and Cl
− absorption in villous cells and 
the stimulation of secretion of Cl
−, HCO3
− and water in epithelial cells resulting in massive electrolyte 
loss and dehydration [151,153,164]. 
Figure 8. Proposed mechanism of cholera toxin (CT) traffic into intestinal epithelial cells. 
The CT holotoxin binds to GM1 in the apical membrane. After endocytosis, the CT-GM1 
complex traffics retrograde through Golgi cisterna into endoplasmic reticulum (ER). Here, 
the A1 subunit is unfolded and dissociated from the B pentamer. The unfolded A1 peptide is 
probably translocated to the cytosol and may then gain access to its substrate, the 
heterotrimeric GTPase Gs on the cytoplasmic surface of the basolateral membrane, by 
diffusion through the cytosol (if the A1 peptide breaks away from the membrane after 
translocation) or by membrane traffic back out of the secretory pathway (if the A1 peptide 
remains membrane associated). The B subunit is not unfolded in the ER, remaining 
membrane associated, probably bound to GM1. It moves to the basolateral membrane by 
trafficking back out the secretory pathway by indirect transcytosis. 
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Strains not carrying ctx genes can also be pathogenic, as they have several virulence factors and can 
produce other toxins like RTX cytotoxins [165], which will be discuss further in the context of toxins 
produced by V. vulnificus. Another V. cholera toxic metabolite is the cholix toxin [153]. The existence 
of the cholix toxin was discovered by detailed analysis of non-01 and non-139 strain genomes that 
revealed the presence of a gene encoding a putative new exotoxin, similar to ExoA from 
Pseudomonas aeruginosa [166].  Toxins 2010, 2  
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Similarly to ExoA toxin from P. aeruginosa, cholix toxin is recognized by the lipoprotein   
receptor-related protein (LRP) of the host cells, enabling access to the cell cytoplasm. However, some 
recent studies performed in LPR receptor-deficient cells point to the existence of other paths for toxin 
entry, as these cells showed some sensitivity to the cholix molecule. Cholix toxin presents a KDEL 
sequence, responsible to direct it to ER, and is activated within the host cell by furin cleavage in an 
Arg-rich loop, together with the reduction of critical disulfide bridges [153]. The toxin is an   
ADP-ribosylating protein that is specific to ribosomal eEF-2 elongation factor. It recognizes eEF-2 as 
the target protein substrate and has both glycohydrolase and ADP-ribosylating activities that are 
necessary to change diphthamide, the post-translationally modified histidine residue of this eukaryotic 
elongation factor. The modification mechanism involves the transfer of the ADP-ribose complex of 
NAD
+ to the diphthamide imidazole in eEF-2 via a nucleophilic substitution were diphthamide 
imidazole is the nucleophile that replaces the nicotinamide base (leaving group) in NAD
+. Exactly how 
ADP-ribosylation of the diphthamide inhibits eEF-2 function remains to be determined. Binding 
experiments of ADP-ribosylated eEF-2 to the ribosome show a reduction of affinity for the   
pre-translocational ribosome, but no changes are observed for the post-translocational ribosome. 
Competition and co-sedimentation experiments have indicated that the ADP-ribosylated eEF-2 is able 
to form a stable complex with the ribosome. However, other binding experiments have shown that 
ADP-ribosylated eEF-2 still has ribosome-dependent GTPase activity and can dissociate from the 
ribosome. These contradictory results confirm that further studies are necessary to obtain a better 
understanding of how these ribosylating toxins inactivates the elongation factor [166]. Nevertheless, 
independently from the mechanism of eEF-2 inactivation, the final consequence for the host cell is the 
inhibition of protein synthesis and cell death. 
This toxic protein is coded by the chxA gene, corresponding to a 666 amino acid residue product 
(634 residues in the mature protein). The first 32 residues correspond to a leader sequence. It presents 
a sequence identity of 33.5% to ExoA (the catalytic domains alone have a sequence identity of 41.3%). 
In addition, chxA contains conserved residues previously shown to be crucial for catalytic 
activity [166]. Full length structure of the protein demonstrated that cholix toxin is composed by three 
different domains (I–III) that are responsible by receptor binding, membrane translocation and enzyme 
catalysis, respectively [153]. 
After diphtheria toxin and ExoA from P. aeruginosa, the V. cholerae cholix toxin is the third 
member of this group of protein synthesis inhibitors described so far. The chxA gene is widely 
distributed in V. cholerae populations, both in clinical and environmental strains. However, the 
specific targets of the toxin and the symbiotic interactions associated with its activity have yet to 
be determined. 
3.1.2. Vibrio vulnificus 
This  Vibrio species is part of the natural microbiota of coastal marine environments and is 
frequently present in water and seafood products like shrimp, fish, oysters and clams [167–169]. It is 
an opportunistic human pathogen, responsible for severe and fulminant systemic infections that are 
highly lethal [170]. Consumption of seafood, especially raw oysters, is the main human contamination 
source. The characteristics of V. vulnificus infections include fever, chills, nausea, hypotensive septic Toxins 2010, 2  
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shock and secondary lesion formation on the extremities of the body [171]. Primary septicemia is the 
most lethal infection, with about 50% mortality rate. In addition, this bacterium can cause serious 
wound infections as a result of exposure to contaminated waters. Wounds are often acquired during 
recreational swimming, fishing or seafood handling [172]. 
Two cytotoxins (an elastolytic protease, VvpE, and a hemolysin, VvhA) were first suggested to be 
responsible for the toxic effects of V. vulnificus [173,174]. However double mutants for the 
corresponding genes did not present significant differences in cytotoxicity from the wild type 
strain  [175]. Later it was shown that V. vulnificus strains are cytotoxic due the production of a   
repeats-in-toxin (RTX) exoprotein [176]. This toxin is also present in several bacterial species 
including V. cholerae, and was first detected in this species, but is the main toxin in V. vulnificus, 
being essential for its virulence and infection.  
RTX toxins, including the RtxA1 from V. vulnificus, primarily promote pore formation in cellular 
membranes, but can also induce changes in cytoskeletal structure, bleb formation and aggregation of 
actin, resulting in cell rounding. In V. vulnificus infection, actin aggregation occurs without covalent 
cross-linking and is a depolymerization process that involves a change in the F/G actin dynamics for 
which Rho GTPases play important roles. These changes can lead to cellular necrosis and are probably 
related with the bacteria’s ability to destroy gastrointestinal epithelial/mucosal barrier and invade 
blood stream soon after infection [176]. RTX operon contains its own processing and ABC transporter 
genes. After production RtxA1 is autoprocessed in at least two parts (approximately 350 and 130 kDa) 
and this activation mechanism is induced by the contact with host factors [176]. Only the processed 
protein can act as cytotoxic factor. 
RTX proteins are usually large molecules, presenting GD-rich nonapeptide repeats 
(GGXGXDX[L/I/V/W/Y/F]X, where X is any amino acid). This structure is thought to be involved in 
the insertion of the toxin in the eukaryotic plasma membrane [165]. However, the toxin of V. vulnificus 
and V. cholerae has some particular characteristics. The repeats are different, falling into three classes, 
presenting divergent sequences, but retaining a central conserved motif (G-7X-GXXN). The class A 
motive is also located in the N-terminus of the protein and not in the C-terminal part. Furthermore, the 
presence of the multifunctional autoprocessing domain in these toxins shows that they are part of a 
particular group of RTX toxins, called multifunctional autoprocessing repeats-in-toxins (MARTX). 
These toxins present several structural features that are different from other RTX toxins [165]. The 
RtxA1 from V. vulnificus is estimated to be the largest RTX toxin known so far. The predicted amino 
acid sequence showed high homology with RtxA from V. cholerae. However, two domains show no 
identity with RtxA and it was hypothesized that these two regions may confer distinct activities to 
these toxins. RtxA1 toxin is likely to be much more cytotoxic to the host cells than RtxA from 
V. cholerae. These two domains may play an important role in pore formation in host cell membrane, 
which can be related with the cytotoxic mechanisms of RtxA1 [176].  
Identification of this toxin was possible by random chromosomal mutagenesis that allowed the 
detection of the corresponding gene (rtxA1). Two additional rtxA genes have also been identified, but 
their function is not clear, as they are not directly involved in cytotoxic activity. The first portion of the 
rtx operon (rtxBDE) includes genes for the type I secretion system that is responsible for the toxin 
secretion [177]. The second part of the operon (rtxAC) includes the rtxC gene that codes for an 
activator of RtxA in V. cholerae, but probably has other function in V. vulnificus, as a mutation in this Toxins 2010, 2  
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gene does not affect toxicity. Other potential regulator of rtxA (HlyU) was also identified in 
V. vulnificus. It is a transcriptional regulator that binds upstream of the rtx operon, initiating 
transcription [178].  
3.2. Aeromonas hydrophila 
Aeromonas spp. are members of Aeromonadaceae that cause both intestinal and systemic infections 
in humans. Aeromonas hydrophila colonizes aquatic environments and is also isolated from food 
products [179]. Although gastroenteritis occurs generally in young children, it has been frequently 
associated with the travel’s diarrhea [180]. Furthermore, the cases of septicemia are often fatal. This 
species can express several virulence factors, including hemolysins, proteases, adhesins, 
lipases/phospholipases and toxins [181]. This bacterium also has the ability to lyse erythrocytes, and 
has shown to be invasive and effective in triggering the proinflammatory response in macrophages and 
epithelial cell lines [179,182]. Act is an aerolisyn-related pore-forming toxin that is responsible for the 
hemolytic, cytotoxic and enterotoxic activities of A. hydrophila, being its main virulence factor.  
Hemolysis involves pore formation in the membrane of the target cell and water entry from the 
external media, resulting in swelling of the cells and subsequent lysis. The toxin interacts with the 
membranes of erythrocytes, inserts into the lipid bilayer as oligomers, and creates pores in the range  
of 1.14 to 2.8 nm. Cholesterol serves as the receptor for Act and the 3’-OH group of this membrane 
constituent is important for the interaction. Once Act has interacted with cholesterol on the cell 
membranes, the toxin is activated with subsequent oligomerization and pore formation [179].  
The toxin activity also includes tissue damage and high fluid secretion in intestinal epithelial cells, 
resulting from the induction of a proinflammatory response in the target cells (Figure 9). Act 
upregulates the production of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-), 
interleukin-1 beta (IL-1) and IL-6 in macrophages. TNF- and IL-1 stimulate the production of the 
inducible nitric oxide synthase (iNOS) that, through nitric oxide (NO) production, is an essential 
element of antimicrobial immunity and host-induced tissue damage. Simultaneously, Act has the 
ability to activate arachidonic acid (AA) metabolism in macrophages that leads to the production of 
eicosanoids (e.g., prostaglandin E2 [PGE2]) coupled to cyclooxygenase-2 (COX-2) pathway. AA is a 
substrate for PGE2 production, but is present at limited concentrations in cells [182]. Act increases the 
amount of AA from phospholipids by inducing group V secretory phospholipase A2 (sPLA2), which 
acts in the membrane of eukaryotic cells. Act increases cyclic AMP (cAMP) production in 
macrophages by indirect activation of adenylate cyclase by PGE2. The A. hydrophyla toxin also 
induces the production of antiapoptotic protein Bcl-2 in macrophages, preventing the occurrence of 
massive apoptosis resulting from the induction of the inflammatory response, which would be 
undesirable for the bacteria. Act also promotes an increased translocation of the nuclear factor kB  
(NF-kB) and cAMP-responsive element binding protein (CREB) to the nucleus [182]. Transcription 
factor NF-kB is important in a number of inflammation-related pathways. The enhancer/promoter 
regions of some immunoregulatory cytokine genes, including the TNF-, IL-1, and IL-6, present 
binding elements for NF-kB and CREB [183]. These transcription factors have also important 
regulatory functions in the transcription of cox-2 and are implicated in the induction of Act 
cytotoxic activities. Toxins 2010, 2  
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The production of proinflammatory cytokines and iNOS causes an extensive tissue injury in the 
intestinal loops. It also loosens the tight junctions around epithelial cells, allowing the influx of 
inflammatory cells into the intestinal lumen and increasing the uptake of Act into lamina propria, 
where inflammatory cells can be activated. Moreover, PGE2 along with cAMP leads to the stimulation 
of fluid secretory response and the subsequent fluid loss [182].  
The mature protein is 52 kDa and contains 493 amino acids. It is secreted as an inactive precursor 
and undergoes processing at both the N- and C-terminal ends to demonstrate biological activity. It has 
a leader sequence of 23 amino acids that allows the protein to transverse the inner membrane. This 
leader peptide is removed when the toxin enters the periplasmic space. After the secretion of Act into 
the medium, a polypeptide of approximately 4–5 kDa (about 45 amino acids) is cleaved from its  
C-terminus by a protease produced by A. hydrophila, resulting in the mature form of the toxin. This 
toxic protein is coded by A. hydrophila act gene, corresponding to a 1479 bp open reading frame. The 
first 69 bp codes for the N-terminal signal peptide. The typical regulatory -35, -10 and Shine-Delgarno 
sequences, as well as the promoter, were identified upstream of the coding region [179,184,185]. 
More recently, two other toxins were detected in A. hydrophila. Alt is a 44 kDa protein,   
with 368 amino acid residues, coded by the corresponding alt gene. The other is Ast, the product of  
a 1911 bp open reading frame that originates a protein of 71 kDa and 636 amino acids. Both represent 
new molecules with no significant homology to other bacterial toxins. Although there is evidence of 
their contribution to the elevated cAMP and prostaglandin E2 levels in infected cells, their specific 
roles must be clarified [181]. 
Figure 9. Act mediated pathways for activation of inflammatory response and apoptosis 
inhibition (see text for details). 
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3.3. Escherichia coli 
Escherichia coli is a genetically heterogeneous group of bacteria from the Enterobacteriaceae 
families, whose members are generally non-pathogenic and are part of the normal microbiota of the 
intestinal tract of humans and animals [186]. However, some strains have acquired genes that enable 
them to cause diseases [187]. These strains can be divided into two types (pathotypes), based on the 
mechanisms and virulence factors by which they cause disease [187]. One of these E. coli pathotypes 
(STEC) [187] corresponds to the enterohemorrhagic strains and is characterized by the production of at 
least one type of Shiga toxin, a family of structurally and functionally related exotoxins, which 
includes the toxin produced by Shigella dysenteriae [188]. This E. coli toxin is also known as 
verotoxin due to its effect in Vero cells. Ruminants, in particular cattle, constitute a vast source of 
STEC and is frequent that human infections are originated in food and water contaminated with cattle 
manure, especially because they are carried by healthy animals [186]. Infections in humans may result 
in water diarrhea, bloody diarrhea or in the hemolytic uremic syndrome (HUS), characterized by acute 
renal failure, hemolytic anemia and other severe symptoms. The kidney and the gastrointestinal tract 
are the most affected organs, but lungs, heart, central nervous system and pancreas can also be 
targeted. HUS develops in 5–10% of individuals infected with STEC O157:H7, the most frequent 
serotype causing this infection in humans [188]. 
Shiga toxins are encoded in the genome of several lambda-like bacteriophages, which represent 
highly mobile genetic elements and play a central role in horizontal gene transfer [189]. Phage stx 
genes are located in the late region, downstream of the late promoters, and are highly expressed during 
the lytic cycle [188]. The folding and assemblage of the toxins are only possible in the particular 
conditions of bacterial periplasm and their release seems to occur by phage mediated bacterial lysis. 
Two types of Shiga toxin are recognized: Stx1 and Stx2, coded by the corresponding genes stx1 and 
stx2. Stx1 is highly conserved in structure and similar to Shiga toxin from S. dysenteriae. However, a 
variant Stx1c was already identified and has been mainly associated to ovine origins [190]. In contrast, 
there are several antigenic variants of Stx2: Stx2c, Stx2d, Stx2d-activatable and Stx2e. Stx2d and 
Stx2e are believed to be associated to mild or asymptomatic diseases and Stx2c is believed to be less 
frequent in patients presenting severe symptoms [186]. 
The Stx molecules (approximately 70 kDa) present an A1B5 hexameric structure of toxins from AB5 
family, in which A subunit (32 kDa) is non-covalently linked to the pentamer of B subunits (7.7 kDa 
each). Subunit A (StxA) is enzymatically active and the B fragments (StxB) are responsible for host 
cell binding [186,188]. StxB binds to the neutral glycosphingolipid globotriaosylceramide (Gb3), 
which is present at the surface of susceptible cells, allowing the internalization of the toxin [191]. Each 
StxB fragment binds to three trisaccharide sites. Sites 1 and 2 mediate high affinity receptor binding 
and are the most relevant for cell cytotoxicity. The third site mediates the recognition of additional low 
affinity Gb3 epitopes [192]. Distinct variants of the Stx toxin present some conformational divergences 
in site 2 and show affinity for Gb3 receptors with different fatty acid chains [193]. After binding to the 
specific receptor in the plasma membrane, Stx enters the cell by endocytosis. The toxin can induce 
endocytic invaginations in the plasma membrane without the help of cell machinery. Membrane 
blending results from the glycosphingolipid receptors aggregation, mediated by Stx [194]. The 
membrane invaginations are then processed by the cell mechanisms, involving dynamin, actin and Toxins 2010, 2  
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membrane cholesterol. After entry into the cell, Shiga toxin localizes in early endosomes, but it 
escapes the late endocytic pathway and is directly transferred to trans-Golgi network (TGN) and then 
to ER. Dynamin and retromer are molecules implicated in membrane blending and have shown to be 
important for the direct transfer of Stx from early endosome to TGN [195,196]. The transport 
mechanism from TGN to ER is unknown, but is independent from the coat protein complex I (COPI). 
Shiga toxin does not induce pore formation in the cell membrane. Like RtxA from V. cholerae, it relies 
on host cell machinery to translocate the A active subunit to the cytosol. During the early entry 
process, a protease sensitive loop in the C-terminal region of StxA (residues 242–261) is cleaved by a  
membrane-associated endoprotease (furin), originating two StxA fragments: the catalytic fragment A1 
(amino acids 1–251) and the StxB associated fragment A2 (amino acids 252–293). A1 domain remains 
linked to StxA2-StxB complex by a disulfide bond, which is reduced in ER lumen, releasing the 
catalytic domain that is subsequently translocated to the cytosol [186,194] (Figure 10). 
Figure 10. Trafficking mechanism of Shiga toxins. Toxin binding to the plasma membrane 
induces membrane-mediated clustering and the toxin-driven endocytosis. The toxin then 
undergoes retrograde sorting in early endosomes, in a dynamin-dependent process. Shiga 
toxins bypass the late endocytic pathway and are transferred directly from the early 
endosome to the trans-Golgi network (TGN) and from there to the endoplasmic reticulum 
(ER). Finally, Shiga toxins use the ER-associated degradation (ERAD) machinery to 
facilitate retrotranslocation into the host cell cytosol. There it can reach its cellular targets. 
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Shiga toxin has a highly specific RNA-glycosidase activity that cleaves an adenine base from the 
28S ribosomal RNA (rRNA) of the eukaryotic ribosome [197]. The 3’ end of 28S rRNA functions in 
the aminoacyl t-RNA binding, peptidyltransferase activity and ribosomal translation. This modification Toxins 2010, 2  
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of ribosomes inhibits the tRNA binding to the ribosome and the subsequent chain elongation. It also 
triggers a signaling response termed ribotoxic response that includes the activation of the JUN   
N-terminal kinase and p38 (a mitogen-activated protein kinase—MAPK), altering the signaling of the 
extracellular signal-regulating kinases ERK1 and ERK2 [198]. The toxin also activates several cellular 
kinases, like tyrosine kinases that phosphorylate several proteins including dynamin, which favors 
toxin uptake, and p38, implicated in ribotoxic response [199]. Shiga toxin damages the 
microcirculation and the intestinal mucosa, leading to bleeding into the bowel and bloody diarrhea. 
This provides essential nutrients to the bacteria, favoring its survival [188]. 
Shiga also induces cytokine synthesis and release. Some monocytes and macrophages are resistant 
to the toxin and respond to toxin binding and internalization by producing and releasing   
pro-inflammatory cytokines, which in turn stimulate the Gb3 biosynthesis and expression in several 
endothelial cells, promoting the cytotoxic action of the toxin. After crossing the intestinal epithelium 
and entering in circulatory system, Stx stimulates the monocytes to secrete cytokines like GM-CFS 
and TNF [200]. Interleukin 8 (IL-8) probably plays a central role in this process. All these reactions 
can contribute to the endothelial cell damage. Furthermore, Stx can signal apoptosis by a mechanism 
that requires retrograde transport through Golgi apparatus and ER and the activation of caspase 3. 
Caspases are cysteine-dependent, aspartate-specific proteases that are a central component of the 
programmed cell death pathway. Shiga toxin induces the ER stress response, a cellular mechanism that 
is usually activated under the accumulation of unfolded and misfolded proteins, leading to Ca
2+ release 
from ER stores [201,202]. Ca
2+ activates cysteine protease calpain that activates caspase 8 through 
cleavage. This last protease directly activates caspase 3, initiating the apoptotic process (Figure 11). 
Figure 11. Apoptosis pathway triggered by induction of ER stress response and Ca
2+ 
mediated calpain activation. 
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Bacterial ribosomes are also susceptible to Stx toxin [203], decreasing the proliferation of susceptible 
bacteria from the intestinal microbiota and allowing a more efficient propagation of the pathogen. 
3.4. Legionella pneumophila 
Legionella pneumophila is the pathogenic organism responsible for the Legionnaires disease, a 
potential lethal pneumonia that results from the ability of this bacterium to survive and replicate in 
macrophages. No animal reservoir is known, but its natural hosts and environmental source are aquatic 
protozoa (e.g., amoebae), in which they replicate and seems to enhance its ability to infect 
mammalians cells [204]. The human infection occurs mostly by inhalation of aerosols generated by 
domestic and environmental water sources [205]. L. pneumophila cells enter the macrophages by 
vacuoles that are immediately surrounded by vesicles or mitochondria and move towards the 
endoplasmic reticulum, escaping from fusion with lysosomes and reaching a perfect niche for their 
multiplication [206]. 
L. pneumophila also produces a toxin of the RTX family (of which the general structure is 
discussed above), a pore-forming protein that has an important role in adherence to host membranes 
and in the molecular traffic of the bacteria during the infection process [207]. Its role in bacterial 
adherence and traffic may be due to the ability of these proteins to bind 2 integrin receptors in the 
target cell membranes [208]. After entering the cell, this toxin induces pore formation in the vacuoles, 
preventing proper docking of lysosomes and fusion. This process allows bacterium survival inside the 
host cell. 
In this species, RTX toxin (RtxA) is a large protein (about 7000 amino acids), with a variable 
number of repeated units and a modular structure. The toxin appears to be clearly divided in two 
regions: the N-terminal, involved in cell adhesion and the C-terminal, involved both in adhesion and 
pore-forming. The repeats at the N-terminal end are also highly variable among strains [209]. Analysis 
of the RtxA genes in several strains showed the existence of long tandem repeats (460–549 bp), 
variable in number and sequence, and with a high level of rearrangements and diversity when 
compared with the flanking regions [209]. The corresponding ORFs range between 4669 to 7910 bp. 
Different kinds of cell adhesion domains were identified in the N-terminal region of rtx genes of the 
diverse strains. Two of these motifs were always present: (i) the von Willebrand factor A (VWA) 
domain, involved in cell membrane adhesion processes, and (ii) other tandem repeat domain with 
homology with the hemolysin calcium-binding site, which is related with adhesion to other host 
surfaces and pore formation [209]. 
Recently a glucosyltransferase from L. pneumophila (Lgt1) was identified. This Legionella enzyme 
(a protein with 60 kDa) modifies the eukaryotic eEF-1A. This elongation factor is a GTP-binding 
protein, possessing GTPase activity. Lgt1 alters the serine-53 of eEF-1A, located in the GTPase 
domain. The modification results in inhibition of protein synthesis both in vitro and in vivo and causes 
extreme changes in cellular morphology and, ultimately, death of intoxicated eukaryotic cells [210]. 
This bacterium is able to multiply inside phagocytes. Toxin expression is only induced after a 
successful replication, when bacteria go out to the surrounding medium, being important to the 
transmission to a new host.  Toxins 2010, 2  
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L. pneumophila have several open reading frames encoding unknown proteins that can correspond 
to unknown toxins and justify further studies on this species. 
3.5. Campylobacter spp. 
The genus Campylobacter includes curved, S-shaped and spiral rods, with a microaerophilic 
metabolism and presenting spherical or coccoid cells in old cultures or under oxygen exposure [211]. 
Two species of this genus (Campylobacter jejuni and Campylobacter coli) are important causes of 
diarrheal diseases worldwide. Campylobacter spp. infections usually cause severe gastroenteritis, but 
can also be responsible for prolonged enteritis, bacteremia, septic arthritis and other infections [212]. 
Campylobacter spp. are zoonotic and many animals are natural reservoirs for human disease, including 
poultry, cows, sheep and pigs. Campylobacters are frequently isolated from water, and water supplies 
have been a source of some outbreaks [211]. The pathogenic mechanisms and virulence factors 
responsible for Campylobacter spp. gastroenteritis are not completely understood, but like other 
enteric pathogens, Campylobacter spp. colonize, invade and transmigrate across human intestinal cells. 
The interaction of the bacteria with the intestinal epithelium induces the production of several   
pro-inflammatory cytokines, including interleukin-8 (IL-8), a major cytokine secreted by the intestinal 
epithelial cells. IL-8 functions as a chemoattractant, recruiting neutrophils to the site of infection, 
contributing to the inflammatory response. One virulence factor already identified is a cytolethal 
distending toxin (CTD) that induces distention of the cytoplasm of infected cell, increase in their DNA 
content and accumulation of the inactive tyrosine phosphorylated form of Cde2, a key regulator of cell 
cycle progression [213]. This type of toxin has already been found in other microorganisms like 
Shigella spp. or Helicobacter  hepaticus [214,215]. This toxin is also implicated in the induction 
mechanism of IL-8 production [216]. CTD is required for IL-8 production, in addition to toll-like 
receptors (TLRs), which play a central role in initiating the inflammatory response. 
Campylobacter jejuni cytotoxic strains secrete CTD by a flagellum mediated mechanism and activate 
NF-kB. The production of this nuclear transcription factor is stimulated both by CTD and TLRs, via 
MyD88 signaling TLRs adaptor, and triggers IL-8 [216]. 
CDT is an AB2 heterodimeric tripartite toxin, composed of three subunits: CdtA, CdtB and CdtC. 
Amino acid sequence of the CtdB subunit shows high similarity with members of DNase A nuclease 
family. Although limited to some residues, they correspond to a motif that is essential for nuclease 
activity. Thus, CtdB is the active subunit of CTD, acting by DNA damaging and stopping cell cycle in 
G2/M phase [217]. CtdA and CtdC fragments are involved in the delivery of the active subunit CtdB 
into the cell [218]. The toxin is encoded by three genes, ctdA, ctdB and ctdC that are located in a 
chromosomal operon. 
4. Water Contaminating Toxin Producing Bacteria  
Other toxigenic species like Clostridium spp. and Pseudomonas spp. are ubiquitous in the 
environment. Even though they are not aquatic microorganisms, they can easily contaminate drinking 
or irrigation waters and become hazards for humans and animals. Some representative examples of 
toxins produced by these bacteria will be briefly referred below. Toxins 2010, 2  
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4.1. Clostridium spp. 
Clostridium is a genus of pleomorphic, gram-positive, anaerobic rods that are widespread in several 
habitats, including soils, wetlands, lakes, coastal waters, intestinal track of fish and gills and viscera of 
crabs and other shellfish [219]. They are highly resistant to adverse environmental conditions as they 
are able to produce endospores. These bacterial spores are cellular structures that can resist to extreme 
temperatures, desiccation, chemicals and radiation. When favorable growth conditions are 
reestablished, the spores can germinate, originating viable vegetative cells [135]. Recreation and 
drinking water can became contaminated with Clostridium spp. spores from sources like soils and dust, 
and insects also contribute for their spread. Clostridium spp. cells are not pathogenic by themselves. 
However several species may produce exotoxins that can be extremely hazardous [219].  
4.1.1. Clostridium botulinum 
Botulism, the disease cause by C. botulinum, is a severe neurological illness that causes paralysis. It 
is originated by a potent neurotoxin produced by this bacterium. Seven antigenically distinct botulism 
toxins (types A, B, C1, D, E, F and G) were identified and are considered among the most toxic 
substances known. Botulism toxins (BoNTs) are water soluble large molecules (150 kDa), produced as 
single peptides. The active toxin is composed by a heavy chain (H) and a light chain (L), linked by a 
disulfide bond. It is originated after proteolytic cleavage by endogenous bacterial proteases [220]. 
BoNTs may form oligomers, which can be involved in channel formation and translocation of the 
protein into the host cytoplasm. The toxin can also form complexes with other proteins such as 
nonhemagglutinin (NTNH) and hemagglutinines [221,222]. These spontaneously formed complexes 
confer toxin resistance to proteases and their association is pH dependent. Complexes are maintained 
at pH lower than 7.2 and spontaneously dissociate at higher values. The toxin acts by blocking the 
neurotransmission at peripheral motor nerve terminals. They selectively hydrolyze proteins involved in 
the fusion of synaptic vesicles with the presynaptic plasma membrane, preventing acetylcholine 
release [223]. This process occurs in four steps: binding, membrane translocation, internalization and 
intracellular action [224]. The H chain is responsible for the selective binding to neurons, 
internalization of the total toxin and intraneuronal sorting. L chain blocks exocytosis after toxin release 
in the cytoplasm [225]. 
The neurotoxin genes are located in a transcriptional unit, together with the genes encoding NTNH 
and hemagglutinins. This unit is referred as BoNT gene complex [226]. The location of BoTN genes 
and associated nontoxic proteins depends on the type of toxin. BoNT A, B, E and F genes are located 
in the bacterial chromosome together with the genes of the corresponding associated proteins [227]. 
BoNT gene complexes of serotypes C1 and D are coded by a bacteriophage [228]. Genes of serotype 
G are located in a plasmid [229]. In each gene complex, NTNH gene is located immediately upstream 
of BoNT genes in all toxin types [226]. Genes for the other components are clustered upstream of 
NTNH gene for most of the toxins. Only C1 type presents a different arrangement, including three 
transcriptional units: (i) the first including NTNH and BoTN genes, (ii) the second composed by three 
genes coding hemagglutinins and (iii) the last one, with only one gene, probably having a regulatory 
function [228]. Toxins 2010, 2  
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4.1.2. Clostridium perfringens 
The virulence of Clostridium perfringens largely results from its ability to produce toxins. At least 
14 different toxins have been identified, but each strain only carries genes for a defined subset of the 
total repertoire. This characteristic provides the basis for a toxin typing system that groups 
C. perfringens isolates into five types (A to E), depending on its ability to produce four (alpha, beta, 
epsilon and iota) of the 14 toxins [230]. The total set of toxins includes two that are active in the 
human intestinal tract: C. perfringens enterotoxin and beta-toxin, each one associated with a distinct 
disease. One is necrotic enteritis, caused by type C strains, with the beta-toxin considered as the main 
virulence factor. This toxin is related to alpha-toxin and leukocidin from Staphylococcus aureus.  
Beta-toxin is considered a single component toxin, presenting a molecular mass of about 35 kDa and 
334 amino acids [202]. The first 27 residues correspond to a signal peptide, directing the export of the 
toxin across the cell membrane. The toxin is encoded by a single open reading frame of approximately 
1006 bp (cpb gene) with the Shine-Dalgarno sequence located at 7 bp upstream the ATG start codon [231]. 
C. perfringens type A is responsible for most of the human diseases caused by this species. The 
symptoms of the infection (diarrhea and cramping) are due to the C. perfringens enterotoxin (CPE), a 
peptide presenting a unique amino acid sequence and mechanism of action. CPE is a thermo-labile 
protein with 319 amino acids, without N-terminal secretion sequence and presenting a molecular mass 
of 35 kDa [232]. The production of this enterotoxin is associated with the sporulation process of 
C. perfringens and can represent more than 10% of the total protein in sporulating cells [232]. The 
toxin is released when the mother cell lyses at the end of the sporulation. Thus, during this process, 
much CPE is accumulated in paracrystalline inclusion bodies in the cytoplasm of C. perfringens 
cells [232]. The action of CPE is a multistep process. It starts with the binding of the toxin to its 
intestinal receptors, inducing the formation of a small complex that entraps CPE at the membrane 
surface. This complex interacts with other proteins, forming a second complex of intermediate size, 
which can interact with occludin (a tight junction protein) or other proteins of the eukaryotic cell. This 
causes the loss of membrane permeability characteristics, probably because the complex has pore-like 
properties or by inducing tight junction rearrangements [211]. The N-terminal end of the toxin has the 
cytotoxic activity and the C-terminus is likely to be involved in binding to cell membrane. The CPE 
coding gene (cpe) can be located either in the bacterial chromosome or in a conjugative plasmid. The 
corresponding ORFs are identical. The expression of cpe is induced by regulators (e.g., alternative 
sigma factor) that are involved in the sporulation process, explaining its high production in sporulating 
cultures [232]. One possible regulator is the Hpr global regulator, as Hpr-like binding sequences have 
been identified upstream and downstream of cpe ORF [233]. Since Hpr is known to repress the 
expression of some genes during exponential growth of Bacillus subtilis, the role of Hpr in CPE 
expression could explain the lack of expression of the toxin in vegetative cells. 
4.2. Pseudomonas aeruginosa 
Pseudomonas is a genus of gram-negative, rod-shaped and mobile bacteria that demonstrate a great 
metabolic diversity and ability to use a high number of organic substrates, including phenol derivatives 
and hydrocarbons [234]. A significant number of species can also produce exopolysaccharides and Toxins 2010, 2  
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create biofilms [235]. These two characteristics highly contribute to their ability to colonize a wide 
range of habitats, being widespread in the environment, including plants, animals, soils and water. 
Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of 
clinical relevance [236]. As with other species, it is ubiquitous in the environment and can easily adapt 
to adverse conditions. The human infections range from acute infections like endocarditis, meningitis 
and septicemia to chronic lung infections in cystic fibrosis patients. Most infections occur in 
immunocompromised patients, like AIDS patients, burn victims or patients undergoing   
chemotherapy [237]. P. aeruginosa presents several virulence factors, including the exotoxin A 
(ExoA/PE). It belongs to the same family of mono-ADP-ribosyltransferases of V. cholerae cholix 
toxin, which catalyses the ADP rybosilation of eukaryotic eEF-2 and consequently inhibits protein 
synthesis [238]. PE is translated from an ORF with 2760 bp as a monocistronic message and is a 
protein of 613 amino acids, resulting from a 638 amino acid precursor that includes a hydrophobic 
leader peptide of 25 amino acids [237]. As described before for cholix toxin, PE presents three distinct 
functional domains. The first, the N-terminal Ia domain (a.a. 1–252) is responsible for cell   
recognition [239]. Afterwards, the toxin enters the cell and is internalized in early endosomes, where it 
is cleaved by the protease furin, originating two fragments: a N-terminal with 28 kDa and a C-terminal 
with 37 kDa [240]. This last one is the active fragment and is released in a pH dependent process. 
Then it is transported to the endoplasmatic reticulum via late endosomes and Rab9-dependent route to 
the trans-Golgi network and finally traveling by the KDEL receptor mediator pathway [241,242]. 
When the enzymatic subunit of PE becomes present in the cytosol, it promotes the ADP ribosylation of 
the eEF-2. The ADP-ribosylation mechanism develops as previously described for cholix toxin, 
inactivating eEF-2 and inhibiting protein synthesis. Consequently, it leads to cell death. 
5. Final Remarks 
Bacteria are ubiquitous in the environment and have the ability to adapt to very different habitats. 
Their survival is often dependent on the production of compounds that help them to attach to 
substrates, compete for nutrients and inhibit the growth of other microorganisms. Many virulence 
factors are products that give them advantages in their original environment, but in a host they function 
as pathogenic mechanisms of disease development. Some of these products represent powerful toxins 
that can lead to host disease and, frequently, to death. On the other hand, water is not only a crucial 
resource but is also a requisite to maintain life. The contamination of water systems by toxigenic 
microorganisms can have a catastrophic impact in health and well being of all living organisms. 
Toxins or toxin producers in water systems can arise either by contamination from other environmental 
sources (e.g., Clostridium spp. [219], P. aeruginosa or E. coli [243]) or because aquatic systems are 
their natural habitats (e.g., cyanobacteria, Vibrio spp. [244] or Aeromonas hydrophila [245]). Microbial 
toxins are very diverse and there are many microorganisms recognized as producers. Although this 
review only focuses on the more relevant toxins and toxin producers, more toxic molecules are 
emerging in other organisms. An overview of the toxins produced by bacteria related to aquatic 
environments is summarized in Table 1. 
In fact, a better knowledge about all aspects of these microorganisms seems crucial. Identification 
of routes and sources of water contamination (Figure 12) will allow the design of preventive actions to Toxins 2010, 2  
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avoid this contamination or to prevent conditions that favor the development of toxic microorganisms 
and toxin production.  
Table 1. Toxins produced by prokaryotes related to aquatic environments. 
Mode of action  Toxin name  Produced by  References
Membrane permeabilizing toxins  Act  A. hydrophila  [179] 
  -Hemolysin  E. coli  [1] 
 
Bifermentolysin 
Botulinolysin 
Chauveolysin 
Histolyticolysin O 
Novyilysin 
Perfringolysin O 
Septicolysin O 
C. bifermentans 
C. botulinum 
C. chauvoei 
C. hystolyticum 
C. novyi A 
C. perfringens 
C. septicum 
[1] 
Toxins affecting membrane traffic Botulinum  neurotoxin C. botulinum  [220] 
Toxins affecting signal transduction 
Cholera toxin  V. cholerae  [151] 
Heat-labile enterotoxin  E. coli  [1] 
Toxins affecting protein synthesis  Cholix toxin  V. cholera  [153] 
 Exotoxin  A  P. aeruginosa  [237] 
  Shiga toxin (verotoxin) E. coli [187] 
 Lgt1  L. pneumophila  [210] 
 RtxA V. vulnificus  [165] 
 RtxA L. pneumophila  [207] 
Toxins inhibiting protein function  Cylindrospermopsin  Cyl. raciborskii 
Umezakia natans 
Aph. ovalisporum 
Raph. curvata 
A. bergii 
Aph. flos-aquae 
Lyngbya wollei 
[82–90] 
 
Microcystins  Microcystis 
Planktothrix 
Oscillatoria 
Nostoc 
Anabaena 
Anabaenopsis 
Hapalosiphon 
Snowella 
Woronichinia 
Arthrospira 
Phormidium 
Plectonema 
Pseudoanabaena 
Synechococcus 
Synechocystis 
[27,51] 
 Nodularins  Nodularia spumigena  [2] Toxins 2010, 2  
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Table 1. Cont. 
Cytoskeleton-affecting toxins  Anatoxin-a and 
homoanatoxin-a 
Anabaena 
Oscillatoria 
Cylindrospermum 
Microcystis 
Aphanizomenon 
Planktothrix 
[32,59, 
100–106] 
 C2  toxin  C. botulinum [246] 
  Cytotoxic necrotizing factors  E. coli  [1] 
DNA damaging  Cytolethal distending toxin  Campylobacter spp.  [213] 
Voltage-gated ions channel blockers  Saxitonin and gonyautoxins  A. circinalis 
Aph. gracile 
C. raciborskii 
L. wollei 
Planktothrix 
[14] 
 
Jamaicamides 
Kalkitoxin 
Antillatoxin 
Lyngbya majuscula  [14] 
Unknown Lypopolysaccharides  (LPS) 
E. coli 
Salmonella spp. 
V. cholera, 
P. aeruginosa 
Cyanobacteria 
[39,133] 
Figure 12. Natural reservoirs of the main bacterial toxin producers and routes for water, 
animal and human contamination.  
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Clarification of the mechanisms of toxin action will certainly open new perspectives for efficient 
antidote as well as vaccine development [246,247]. Furthermore, the potential of these toxic products 
as anticancer, antifungal or antibiotic drugs are now recognized and can be an important source for 
biomedical and biotechnological applications in the near future [188,237,246]. Toxins 2010, 2  
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